MD Magazine: Specialty: Ophthalmology Copyright (c) 2017 Intellisphere, LLC. All rights reserved. http://www.mdmag.com/specialty/ophthalmology/rss Ophthalmology en-us Mon, 17 Dec 2018 15:49:28 UTC Researchers Planning Human Trials for Anti-VEGF Eye Drops http://www.mdmag.com/medical-news/researchers-planning-human-trials-for-antivegf-eye-drops Mon, 17 Dec 2018 10:00:00 UTC Novel Imaging Technique Provides Potential Improvement for AMD http://www.mdmag.com/medical-news/novel-imaging-technique-provides-potential-improvement-for-amd Fri, 14 Dec 2018 14:00:00 UTC High-Dose ITVA Found Considered Safe, Cost-Effective Alternative to Anti-VEGF http://www.mdmag.com/medical-news/high-dose-itva-found-considered-safe-costeffective-alternative-to-anti-vegf Thu, 06 Dec 2018 16:00:00 UTC OPT-302 Improves Acuity in Combination with Aflibercept http://www.mdmag.com/medical-news/opt302-improves-acuity-in-combination-with-aflibercept Wed, 05 Dec 2018 14:00:00 UTC Zimura/Lucentis Combo Safe, But Company Decides Not to Move Forward http://www.mdmag.com/medical-news/zimura-lucentis-combo-safe-but-company-decides-not-to-move-forward Tue, 04 Dec 2018 16:00:00 UTC FDA Approves Dextenza for Post-Ophthalmic Surgery Pain Management http://www.mdmag.com/medical-news/fda-approves-dextenza-for-postophthalmic-surgery-pain-management Mon, 03 Dec 2018 21:54:00 UTC Macular Degeneration Patient Visual Hallucinations Associated with Retina http://www.mdmag.com/medical-news/macular-degeneration-patient-visual-hallucinations-associated-with-retina Mon, 03 Dec 2018 12:00:00 UTC Atypical Protein Kinase C Targeted in Anti-VEGF Unresponsive Patients http://www.mdmag.com/medical-news/atypical-protein-kinase-c-targeted-in-antivegf-unresponsive-patients Tue, 13 Nov 2018 12:00:00 UTC Key Anti-VEGF Therapies Have Big Advantages and Drawbacks http://www.mdmag.com/medical-news/key-antivegf-therapies-have-big-advantages-but-also-drawbacks Mon, 05 Nov 2018 10:00:00 UTC Nathan Radcliffe, MD: Benefits of Combo Eye Drops for Glaucoma http://www.mdmag.com/conference-coverage/aao-2018/nathan-radcliffe-md-benefits-combo-eye-drops-for-glaucoma Fri, 02 Nov 2018 16:59:00 UTC Switching to Aflibercept from Ranibizumab Improved DME Outcomes http://www.mdmag.com/conference-coverage/aao-2018/switching-to-aflibercept-from-ranibizumab-improved-dme-outcomes Thu, 01 Nov 2018 13:00:00 UTC Reading Center Assessments Support Aflibercept Monotherapy for Polypoidal Choroidal Vasculopathy http://www.mdmag.com/conference-coverage/aao-2018/reading-center-assessments-support-aflibercept-monotherapy-polypoidal-choroidal-vasculopathy Wed, 31 Oct 2018 19:35:00 UTC Elad Moisseiev, MD: Accuracy and Precision in Intravitreal Injections http://www.mdmag.com/conference-coverage/aao-2018/elad-moisseiev-md-accuracy-and-precision-in-intravitreal-injections Wed, 31 Oct 2018 13:00:00 UTC Ronald Gentile, MD: Pain Management and Anti-VEGF Adherence http://www.mdmag.com/conference-coverage/aao-2018/ronald-gentile-pain-management-anti-vegf-adherence Tue, 30 Oct 2018 13:00:00 UTC Ted Smith MD, PhD: The Future of Retinal Imaging in AMD Detection http://www.mdmag.com/conference-coverage/aao-2018/ted-smith-md-phd-the-future-of-retinal-imaging-in-amd-detection Tue, 30 Oct 2018 12:49:00 UTC Location Crucial to Corticosteroid Treatment for Uveitic Macular Edema http://www.mdmag.com/conference-coverage/aao-2018/location-crucial-to-corticosteroid-treatment-for-uveitic-macular-edema Tue, 30 Oct 2018 09:00:00 UTC Early IVA Conversion Linked to Reduced Vision Loss But At What Cost? http://www.mdmag.com/conference-coverage/aao-2018/early-iva-conversion-linked-to-reduced-vision-loss-but-at-what-cost Mon, 29 Oct 2018 22:08:00 UTC Four Year Analysis Reports Uptick in Aflibercept Use, Decrease in Ranibizumab http://www.mdmag.com/conference-coverage/aao-2018/four-year-analysis-reports-uptick-in-aflibercept-use-decrease-in-ranibizumab Mon, 29 Oct 2018 17:49:00 UTC Faricimab Outperforms Ranibizumab Despite Reduced Dosing Frequency http://www.mdmag.com/conference-coverage/aao-2018/faricimab-outperforms-ranibizumab-despite-reduced-dosing-frequency Mon, 29 Oct 2018 17:00:00 UTC 18-Month Results of the FILLY Trial in Geographic Atrophy http://www.mdmag.com/conference-coverage/aao-2018/18-month-results-of-the-filly-trial-in-geographic-atrophy Mon, 29 Oct 2018 12:00:00 UTC EVADE Study Evaluates Treat and Extend Use for IAI for DME http://www.mdmag.com/conference-coverage/aao-2018/evade-study-evaluates-treat-and-extend-use-for-iai-for-dme Mon, 29 Oct 2018 11:00:00 UTC Shorter Wait Times Linked to Higher-Rated Online Physician Reviews http://www.mdmag.com/conference-coverage/aao-2018/shorter-wait-times-linked-to-higher-rated-online-physician-reviews Sun, 28 Oct 2018 22:57:00 UTC Metformin Shown to Decrease AMD Risk in Diabetes Patients http://www.mdmag.com/conference-coverage/aao-2018/metformin-shown-to-decrease-amd-risk-in-diabetes-patients Sun, 28 Oct 2018 17:18:00 UTC At 96 Weeks Brolucizumab Outdoes Aflibercept in Reducing Retinal Fluid http://www.mdmag.com/conference-coverage/aao-2018/at-96-weeks-brolucizumab-outdoes-aflibercept-reducing-retinal-fluid Sun, 28 Oct 2018 14:13:00 UTC Peter Campochiaro, MD: The Burden of Anti-VEGF Injections http://www.mdmag.com/conference-coverage/aao-2018/peter-campochiaro-md-burden-of-antivegf-injections Sun, 28 Oct 2018 13:00:00 UTC Patrik De Haes, MD: What's Coming Down the Retina Pipeline http://www.mdmag.com/conference-coverage/aao-2018/patrik-de-haes-md-whats-coming-down-the-retina-pipeline Sun, 28 Oct 2018 11:00:00 UTC RGX-314 Gene Therapy for Wet AMD Well Tolerated at 24 Weeks http://www.mdmag.com/conference-coverage/aao-2018/rgx314-gene-therapy-for-wet-amd-well-tolerated-at-24-weeks Sun, 28 Oct 2018 02:26:00 UTC Ted Smith, MD, PhD: Collaboration and Advancements in the Retina Space http://www.mdmag.com/conference-coverage/aao-2018/ted-smith-md-phd-collaboration-advancements-retina-space Sat, 27 Oct 2018 20:43:00 UTC David Brown, MD: Teamwork and AMD/DME Research on the Horizon http://www.mdmag.com/conference-coverage/aao-2018/david-brown-md-teamwork-amd-dme-research-on-the-horizon Sat, 27 Oct 2018 16:14:00 UTC Implantable Ranibizumab Port for Wet AMD Lasts Up to 15 Months http://www.mdmag.com/conference-coverage/aao-2018/implantable-ranibizumab-port-wet-amd-lasts-15-months Fri, 26 Oct 2018 22:36:00 UTC